Acellera

Acellera is a leading brand that has been supporting applied research in the field of biomedical simulation methods and machine learning predictors since 2006. With collaborative agreements with academic institutions, Acellera has been instrumental in the development of cutting-edge scientific solutions for drug discovery. Their product offerings include drug discovery services, where they provide answers for target-validation, hit-identification, hit-to-lead, and lead optimization.

They also offer technology partnerships, allowing customers to build or enhance their platforms by integrating novel scientific solutions. Additionally, Acellera offers preclinical partnerships, enabling collaboration on drug discovery programs to increase pipeline growth. Acellera's software platforms, ACEMD and PlayMolecule, provide advanced molecular simulation environments for biomolecular research.

ACEMD is a powerful molecular simulation programmable environment, while PlayMolecule is a computable drug discovery virtual environment. Both platforms simplify protein-ligand binding predictions and explore the innovative Alchemical Transfer Method. In addition, Acellera offers a range of resources, including software documentation, a web front-end to the PlayMolecule platform, and a blog for news and updates.

Those interested in learning more about the science behind Acellera can explore their publications. Acellera is dedicated to driving advancements in computable drug discovery through scientific collaborations and offers opportunities for researchers and potential investors to get involved. Contact Acellera today to learn more about their innovative solutions and join them in their mission towards revolutionizing drug discovery